Citigroup »

Biomarin Pharmaceutical shares owned by Citigroup

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.4M 9.8M 0.96
2024-12-31 $724k 780k 0.93

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Biomarin Pharmaceutical

Tenor Capital Management
Oaktree Capital Management
Capstone Investment Advisors
BlackRock
Man Group
Opti Capital Management
MacKay Shields
Lazard Asset Management
Toronto-Dominion Bank
Verition Fund Management
Victory Capital Management
Thrivent Financial for Lutherans
State Street Corporation
DeepCurrents Investment Group
Citigroup

View all funds holding Biomarin Pharmaceutical